Japan's Generic Market Primed For Growth, But Distribution And Manufacturing Barriers Remain
This article was originally published in PharmAsia News
Executive Summary
Substantial patent expirations in the next few years and government incentives for generic use make Japan's generic market ideal for midterm growth, but stringent API standards and complex distribution channels have left some foreign firms in a difficult spot.